Spot XRP exchange-traded funds (ETFs) have drawn nearly $1.5 billion in cumulative inflows, indicating growing institutional interest in the XRP market. The sector’s total net assets stand at $997 million, as the funds move closer to surpassing the $1 billion threshold. The increase in capital inflow arrives as technical analysis tools signal a potential rally in the price of XRP.
XRP ETF inflows reach $1.49 billion as analysts target breakout above $1.13
Institutional demand for XRP ETFs strengthens
Professional investors have continued to drive demand for spot XRP ETFs. On the most recent trading session, Bitwise’s XRP ETF registered $4.41 million in net inflows, while Franklin Templeton’s product attracted $2.38 million. These movements reflect ongoing interest from institutional participants, even as XRP’s price consolidates.
Cumulative inflows into these ETFs since their inception now total $1.49 billion, according to data provided by analyst Xaif Crypto. This figure reflects the overall amount of capital that investors have placed into XRP ETFs, separate from the value of XRP currently held by the funds. The rising inflow points to sustained institutional accumulation and a longer-term outlook for the asset, rather than short-term speculative activity.
In the view of market participants, nearing $1.5 billion in cumulative inflows marks a notable milestone for XRP’s institutional adoption, as continued confidence drives investment from both existing and new entrants to the market.
Mini dictionary: Bitwise and Franklin Templeton are major US-based asset management firms known for launching and managing cryptocurrency funds and exchange-traded products targeting institutional investors.
Factors driving ETF growth and XRP demand
ETFs provide institutions with a regulated and accessible method of gaining exposure to XRP, without handling private wallets or crypto exchange accounts. As fresh capital flows into these vehicles, ETF issuers purchase additional XRP to back each new share, adding continuous demand for the asset.
Rising interest in XRP ETFs coincides with Ripple’s ongoing development of enterprise-grade financial partnerships, broader adoption of the XRP Ledger for payment settlement and asset tokenization, and clearer regulatory pathways in several jurisdictions.
Technical indicators hint at bullish breakout
Crypto analyst Ali Martinez noted that XRP’s monthly chart has generated a TD Sequential buy signal, which traders view as a potential end to corrective moves and the start of a new bullish trend. On shorter timeframes, XRP’s price action is locked within a symmetrical triangle, a chart pattern commonly associated with major breakouts.
According to Martinez, a sustained move above $1.13 could set the stage for a 20% rally, targeting a price near $1.35. Currently, XRP sits at $1.08, as reported by CoinCodex, placing it just below this critical resistance zone.
Analysts suggest that if institutional inflows remain strong and technical signals maintain their momentum, XRP could be poised for one of its largest breakout attempts in recent months.
| Bitwise | $4.41 million | N/A | Part of $1.49 billion total |
| Franklin Templeton | $2.38 million | N/A | Part of $1.49 billion total |
| All Spot XRP ETFs | N/A | $997 million | $1.49 billion |
With strong institutional inflows and technical patterns pointing toward upward potential, observers continue to monitor whether XRP can break past the $1.13 barrier and trigger a new phase of market momentum.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
